Brief: Spago Nanomedical Q2 Operating Loss Widens To SEK 4.5 Mln
Aug 22 (Reuters) - Spago Nanomedical AB (publ) SPAGO.TE :
* Q2 OPERATING LOSS SEK 4.5 MILLION VERSUS LOSS SEK 3.1
MILLION
* Q2 NET SALES SEK 30,000 VERSUS SEK 0 YEAR AGO
Source text for Eikon: ID:nNDL8hKFML
Further company coverage: SPAGO.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose